Obsurge Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 30-07-2024
- Paid Up Capital ₹ 2.82 M
as on 30-07-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.59 M
as on 30-07-2024
- Satisfied Charges ₹ 5.02 Cr
as on 30-07-2024
- Revenue 10.30%
(FY 2023)
- Profit -40.01%
(FY 2023)
- Ebitda -30.28%
(FY 2023)
- Net Worth 19.16%
(FY 2023)
- Total Assets 15.03%
(FY 2023)
About Obsurge Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.82 M.
The company currently has active open charges totaling ₹2.59 M. The company has closed loans amounting to ₹5.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jaswant Chauhan, Latish Malhotra, Avijit Chauhan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232DL2002PLC113701
- Company No.
113701
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Obsurge Biotech Limited offer?
Obsurge Biotech Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Health Conditions, Heart Care, Bone, Joint & Muscle Care, Skin Care, Sanitizers & Handwash, Mosquito Repellents.
Who are the key members and board of directors at Obsurge Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avijit Chauhan  | Managing Director | 07-Jan-2008 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amin Aziz | Director | 03-Apr-2015 | Current |
| Jaswant Chauhan | Director | 04-Jan-2002 | Current |
| Latish Malhotra | Whole-Time Director | 04-Jan-2002 | Current |
Financial Performance and Corporate Structure Insights of Obsurge Biotech.
Obsurge Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.3% increase. The company also saw a substantial fall in profitability, with a 40.01% decrease in profit. The company's net worth Soared by an impressive increase of 19.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Obsurge Biotech?
In 2023, Obsurge Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2022 | ₹2.59 M | Open |
Hdfc Bank Limited Creation Date: 30 May 2018 | ₹2.00 Cr | Satisfied |
Citibank N.A Creation Date: 28 Feb 2013 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Obsurge Biotech?
Obsurge Biotech has a workforce of 550 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Obsurge Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Obsurge Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
